Manages pain severe enough to require an opioid analgesic. ANDA 75499, held by Apotex. Butorphanol Tartrate.
As of Nov 16, 2026, ANDA 75499 (Butorphanol Tartrate), held by Apotex, was first approved by FDA on Dec 4, 2002, with 16 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Butorphanol tartrate nasal spray is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Limitations of Use: Because of the risks of addiction, abuse, and misuse, with opioids, which can occur at any dosage or duration reserve butorphanol tartrate nasal spray for use in patients for whom alternative treatment options (e.g.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 4, 2002 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Butorphanol Tartrate1MG/SPRAY · spray, metered;nasal | Butorphanol Tartrate | Rx |
| Jun 18, 2026 | Supplement 39REMS | Approved | None posted |
| Dec 22, 2025 | Supplement 38Labeling · Standard review | Approved | None posted |
| Dec 22, 2025 | Supplement 35Labeling · Standard review | Approved | None posted |
| Oct 31, 2024 | Supplement 36REMS | Approved | None posted |
| Dec 15, 2023 | Supplement 34Labeling · Standard review | Approved | None posted |
| Dec 15, 2023 | Supplement 33Labeling · Standard review | Approved | None posted |
| Mar 5, 2021 | Supplement 28Labeling · Standard review | Approved | None posted |
| Oct 9, 2019 | Supplement 26Labeling · Standard review | Approved | None posted |
| Sep 20, 2018 | Supplement 25Labeling · Standard review | Approved | None posted |
| Sep 18, 2018 | Supplement 24REMS | Approved | None posted |
| Mar 23, 2017 | Supplement 22Labeling · Standard review | Approved | None posted |
| Dec 16, 2016 | Supplement 20Labeling · Standard review | Approved | None posted |
| Dec 16, 2016 | Supplement 18Labeling · Standard review | Approved | None posted |
| May 6, 2009 | Supplement 11Labeling | Approved | None posted |
| Mar 19, 2007 | Supplement 7Labeling | Approved | None posted |
| Apr 28, 2004 | Supplement 2Labeling | Approved | None posted |
| Dec 4, 2002 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters